GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)

BRIEF

published on 05/13/2025 at 22:05, 16 days 22 hours ago

Les actionnaires de GenSight Biologics approuvent la majorité des résolutions du conseil d'administration

Assemblée Des Actionnaires GenSight Biologics LUMEVOQ® Résolutions Du Conseil D'administration Phase III RECOVER
BRIEF

published on 05/13/2025 at 22:05, 16 days 22 hours ago

GenSight Biologics Shareholders Approve Majority of Board's Resolutions

Shareholder Meeting Board Resolutions GenSight Biologics LUMEVOQ® Phase III RECOVER
PRESS RELEASE

published on 05/13/2025 at 22:00, 16 days 23 hours ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’Administration lors de son assemblée générale mixte du 13 mai 2025. La société biopharmaceutique GenSight Biologics se concentre sur le développement de thérapies géniques pour les maladies neurodégénératives

Assemblée Générale Resolutions GenSight Biologics Thérapies Géniques Neurodégénératives
PRESS RELEASE

published on 05/13/2025 at 22:00, 16 days 23 hours ago

Inside Information / Other news releases
GenSight Biologics announces approval of all resolutions at Combined General Meeting on May 13, 2025. Company highlights achievements of 2024 and strategic priorities for 2025

Strategic Priorities Approval Combined General Meeting GenSight Biologics Achievements
BRIEF

published on 04/23/2025 at 20:35, 1 month 7 days ago

GenSight Biologics Announces Annual General Meeting Details

Annual General Meeting Shareholders Gene Therapy GenSight Biologics Retinal Diseases
BRIEF

published on 04/23/2025 at 20:35, 1 month 7 days ago

GenSight Biologics annonce les détails de son assemblée générale annuelle

Actionnaires Assemblée Générale Annuelle Thérapie Génique GenSight Biologics Maladies De La Rétine
PRESS RELEASE

published on 04/23/2025 at 20:30, 1 month 7 days ago

Inside Information / Other news releases
GenSight Biologics to hold Annual General Meeting on May 13, 2025 at 2:00 pm CEST in Paris, France. Procedures for obtaining preparatory documents outlined

Annual General Meeting Preparatory Documents GenSight Biologics Gene Therapies Retinal Diseases
PRESS RELEASE

published on 04/23/2025 at 20:30, 1 month 7 days ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce son Assemblée Générale Mixte le 13 mai 2025 à Paris. Documents préparatoires disponibles en ligne

Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Neurodégénératives
BRIEF

published on 04/08/2025 at 07:51, 1 month 22 days ago

GenSight Biologics Files its 2024 Universal Registration Document

AMF Gene Therapy Registration Document GenSight Biologics Retina
BRIEF

published on 04/08/2025 at 07:51, 1 month 22 days ago

GenSight Biologics Dépose son Document d’Enregistrement Universel 2024

AMF Thérapie Génique Document D'enregistrement GenSight Biologics Rétine

Published on 05/30/2025 at 20:30, 30 minutes ago

BEACN Announces 2025 Q1 Results
Published on 05/30/2025 at 19:30, 1 hour 30 minutes ago

Core Assets Announces Effective Date of Share Consolidation and Name Change
Published on 05/30/2025 at 15:30, 5 hours 30 minutes ago

Silver Spruce Signs Amended Option Agreement, Provides Exploration Update on Pino de Plata Project, Chihuahua, Mexico
Published on 05/30/2025 at 15:00, 6 hours ago

Future Fuels and VRIFY Forge Partnership to Advance District-Scale Uranium Exploration in Nunavut's Hornby Basin
Published on 05/30/2025 at 15:00, 6 hours ago

Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

View all ACCESSWIRE

Published on 05/30/2025 at 20:30, 30 minutes ago

IUTE GROUP ISSUES EUR 140 MILLION NEW SENIOR SECURED EUR 2025/2030 BONDS – Strong demand from existing investors and new subscriptions
Published on 05/30/2025 at 18:05, 2 hours 55 minutes ago

Eurobattery Minerals will submit additional documentation for the EPA at the end of June
Published on 05/30/2025 at 18:04, 2 hours 56 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/30/2025 at 18:00, 3 hours ago

XTransfer participera pour la première fois en tant que sponsor 4 étoiles au salon Money20/20 Europe 2025
Published on 05/30/2025 at 17:38, 3 hours 21 minutes ago

Issue of Equity

View all EQS

Published on 05/30/2025 at 18:14, 2 hours 45 minutes ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 1 day 22 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 1 day 22 hours ago

Engagements collectifs de conservation de titres de la société
Published on 05/28/2025 at 18:39, 2 days 2 hours ago

Descriptif du programme de rachat d'actions - Mai 2025
Published on 05/28/2025 at 18:39, 2 days 2 hours ago

Description of share-buyback program - May 2025

View all LES ECHOS COMFI WIRE

News